Cargando…
Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness
BACKGROUND: The Discoidin Domain Receptor 1 (DDR1) is one of the two members of a unique family of receptor tyrosine kinase receptors that signal in response to collagen, which has been implicated in cancer progression. Here, we examined the expression of DDR1 in prostate cancer (PCa), and assessed...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456559/ https://www.ncbi.nlm.nih.gov/pubmed/34548097 http://dx.doi.org/10.1186/s12935-021-02206-1 |
_version_ | 1784570890749476864 |
---|---|
author | Bonfil, R. Daniel Chen, Wei Vranic, Semir Sohail, Anjum Shi, Dongping Jang, Hyejeong Kim, Hyeong-Reh Prunotto, Marco Fridman, Rafael |
author_facet | Bonfil, R. Daniel Chen, Wei Vranic, Semir Sohail, Anjum Shi, Dongping Jang, Hyejeong Kim, Hyeong-Reh Prunotto, Marco Fridman, Rafael |
author_sort | Bonfil, R. Daniel |
collection | PubMed |
description | BACKGROUND: The Discoidin Domain Receptor 1 (DDR1) is one of the two members of a unique family of receptor tyrosine kinase receptors that signal in response to collagen, which has been implicated in cancer progression. Here, we examined the expression of DDR1 in prostate cancer (PCa), and assessed its potential value as a prognostic marker, as a function of grade, stage and other clinicopathologic parameters. METHODS: We investigated the association between the expression level and subcellular localization of DDR1 protein and PCa aggressiveness by immunohistochemistry, using tissue microarrays (TMAs) encompassing 200 cases of PCa with various Gleason scores (GS) and pathologic stages with matched normal tissue, and a highly specific monoclonal antibody. RESULTS: DDR1 was found to be localized in the membrane, cytoplasm, and nuclear compartments of both normal and cancerous prostate epithelial cells. Analyses of DDR1 expression in low GS (≤ 7[3 + 4]) vs high GS (≥ 7[4 + 3]) tissues showed no differences in nuclear or cytoplasmic DDR1in either cancerous or adjacent normal tissue cores. However, relative to normal-matched tissue, the percentage of cases with higher membranous DDR1 expression was significantly lower in high vs. low GS cancers. Although nuclear localization of DDR1 was consistently detected in our tissue samples and also in cultured human PCa and normal prostate-derived cell lines, its presence in that site could not be associated with disease aggressiveness. No associations between DDR1 expression and overall survival or biochemical recurrence were found in this cohort of patients. CONCLUSION: The data obtained through multivariate logistic regression model analysis suggest that the level of membranous DDR1 expression status may represent a potential biomarker of utility for better determination of PCa aggressiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02206-1. |
format | Online Article Text |
id | pubmed-8456559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84565592021-09-22 Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness Bonfil, R. Daniel Chen, Wei Vranic, Semir Sohail, Anjum Shi, Dongping Jang, Hyejeong Kim, Hyeong-Reh Prunotto, Marco Fridman, Rafael Cancer Cell Int Primary Research BACKGROUND: The Discoidin Domain Receptor 1 (DDR1) is one of the two members of a unique family of receptor tyrosine kinase receptors that signal in response to collagen, which has been implicated in cancer progression. Here, we examined the expression of DDR1 in prostate cancer (PCa), and assessed its potential value as a prognostic marker, as a function of grade, stage and other clinicopathologic parameters. METHODS: We investigated the association between the expression level and subcellular localization of DDR1 protein and PCa aggressiveness by immunohistochemistry, using tissue microarrays (TMAs) encompassing 200 cases of PCa with various Gleason scores (GS) and pathologic stages with matched normal tissue, and a highly specific monoclonal antibody. RESULTS: DDR1 was found to be localized in the membrane, cytoplasm, and nuclear compartments of both normal and cancerous prostate epithelial cells. Analyses of DDR1 expression in low GS (≤ 7[3 + 4]) vs high GS (≥ 7[4 + 3]) tissues showed no differences in nuclear or cytoplasmic DDR1in either cancerous or adjacent normal tissue cores. However, relative to normal-matched tissue, the percentage of cases with higher membranous DDR1 expression was significantly lower in high vs. low GS cancers. Although nuclear localization of DDR1 was consistently detected in our tissue samples and also in cultured human PCa and normal prostate-derived cell lines, its presence in that site could not be associated with disease aggressiveness. No associations between DDR1 expression and overall survival or biochemical recurrence were found in this cohort of patients. CONCLUSION: The data obtained through multivariate logistic regression model analysis suggest that the level of membranous DDR1 expression status may represent a potential biomarker of utility for better determination of PCa aggressiveness. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02206-1. BioMed Central 2021-09-21 /pmc/articles/PMC8456559/ /pubmed/34548097 http://dx.doi.org/10.1186/s12935-021-02206-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Bonfil, R. Daniel Chen, Wei Vranic, Semir Sohail, Anjum Shi, Dongping Jang, Hyejeong Kim, Hyeong-Reh Prunotto, Marco Fridman, Rafael Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness |
title | Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness |
title_full | Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness |
title_fullStr | Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness |
title_full_unstemmed | Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness |
title_short | Expression and subcellular localization of Discoidin Domain Receptor 1 (DDR1) define prostate cancer aggressiveness |
title_sort | expression and subcellular localization of discoidin domain receptor 1 (ddr1) define prostate cancer aggressiveness |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456559/ https://www.ncbi.nlm.nih.gov/pubmed/34548097 http://dx.doi.org/10.1186/s12935-021-02206-1 |
work_keys_str_mv | AT bonfilrdaniel expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness AT chenwei expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness AT vranicsemir expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness AT sohailanjum expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness AT shidongping expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness AT janghyejeong expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness AT kimhyeongreh expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness AT prunottomarco expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness AT fridmanrafael expressionandsubcellularlocalizationofdiscoidindomainreceptor1ddr1defineprostatecanceraggressiveness |